@article{c398677184ad47cb96136bb4560ea5a6,
title = "Editorial: safety in numbers—cycling of biologics does not increase risk of adverse outcomes",
author = "Faye, {Adam S.} and Axelrad, {Jordan E.}",
note = "Funding Information: Jordan Axelrad receives research support from the Crohn{\textquoteright}s and Colitis Foundation, the Judith & Stewart Colton Center for Autoimmunity, Lyanne and Michael Saperstein and the NIH NIDDK Diseases K23DK124570. Adam S. Faye reports research Support from Crohn{\textquoteright}s and Colitis Foundation. Funding Information: Declaration of personal interests: Jordan E. Axelrad has served as a consultatnt and/or advisory board member for BioFire Diagnostics, Janssen, and Abbvie, and has received research funding from BioFire Diagnostics. Adam S. Faye has served as a consultant for Janssen.",
year = "2022",
month = jun,
doi = "10.1111/apt.16936",
language = "English",
volume = "55",
pages = "1459--1460",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "John Wiley and Sons Inc.",
number = "11",
}